DK0652228T3 - Urethaner og urinstoffer, som fremkalder cytoproduktion - Google Patents

Urethaner og urinstoffer, som fremkalder cytoproduktion

Info

Publication number
DK0652228T3
DK0652228T3 DK94106123.6T DK94106123T DK0652228T3 DK 0652228 T3 DK0652228 T3 DK 0652228T3 DK 94106123 T DK94106123 T DK 94106123T DK 0652228 T3 DK0652228 T3 DK 0652228T3
Authority
DK
Denmark
Prior art keywords
urethanes
ureas
cytoproduction
induce
compounds
Prior art date
Application number
DK94106123.6T
Other languages
Danish (da)
English (en)
Inventor
Steven R Schow
Semiramis Ayral-Kaloustian
Mila T Du
James J Gibbons Jr
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0652228T3 publication Critical patent/DK0652228T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94106123.6T 1993-05-12 1994-04-20 Urethaner og urinstoffer, som fremkalder cytoproduktion DK0652228T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/063,174 US5312831A (en) 1993-05-12 1993-05-12 Urethanes and ureas that induce cytokine production

Publications (1)

Publication Number Publication Date
DK0652228T3 true DK0652228T3 (da) 1996-11-25

Family

ID=22047440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94106123.6T DK0652228T3 (da) 1993-05-12 1994-04-20 Urethaner og urinstoffer, som fremkalder cytoproduktion

Country Status (26)

Country Link
US (6) US5312831A (hu)
EP (1) EP0652228B1 (hu)
JP (1) JP3583469B2 (hu)
KR (1) KR100296543B1 (hu)
CN (1) CN1094943C (hu)
AT (1) ATE144533T1 (hu)
AU (1) AU669064B2 (hu)
CA (1) CA2123261A1 (hu)
CZ (1) CZ290445B6 (hu)
DE (1) DE69400798T2 (hu)
DK (1) DK0652228T3 (hu)
ES (1) ES2094004T3 (hu)
FI (1) FI942186A (hu)
GR (1) GR3022253T3 (hu)
HU (1) HU219768B (hu)
IL (1) IL109602A (hu)
NO (1) NO311223B1 (hu)
NZ (1) NZ260507A (hu)
PH (1) PH30182A (hu)
PL (1) PL179984B1 (hu)
RU (1) RU2135515C1 (hu)
SG (1) SG43071A1 (hu)
SI (1) SI0652228T1 (hu)
SK (1) SK281120B6 (hu)
TW (1) TW380129B (hu)
ZA (1) ZA943266B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007183A3 (fr) * 1993-06-18 1995-04-18 Solvay Ureines derivees d'alpha, omega-diaminoacides et procede pour leur preparation.
JPH11503110A (ja) 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
CZ425698A3 (cs) 1996-06-27 1999-06-16 Smithkline Beecham Corporation Antagonista IL-8 receptoru
IL127666A0 (en) * 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
JP2000516620A (ja) * 1996-08-15 2000-12-12 スミスクライン・ビーチャム・コーポレイション Ｉｌ―８レセプターアンタゴニスト
CN1305846C (zh) * 1998-03-26 2007-03-21 参天制药株式会社 脲衍生物
US7465754B1 (en) 1999-09-15 2008-12-16 Wyeth Method of potentiating chemotherapy and treating solid tumors
US7332158B2 (en) 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
AR041834A1 (es) * 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
US20060057121A1 (en) * 2004-09-10 2006-03-16 Demao Yang Compositions and treatments using ex vivo activated cells for myelosuppressed patients
PL2009992T3 (pl) * 2006-04-21 2012-11-30 Glaxosmithkline Llc Antagoniści receptora IL-8
AU2007240364A1 (en) * 2006-04-21 2007-11-01 Smithkline Beecham Corporation IL-8 receptor antagonists
PE20080943A1 (es) * 2006-06-23 2008-09-27 Smithkline Beecham Corp Sal toluenosulfonato de 4-{[6-cloro-3-({[(2-cloro-3-fluorofenil)amino]carbonil}amino)-2-hidroxifenil]sulfonil}-1-piperazinacarboxilato de 1,1-dimetiletilo como antagonista del receptor de il-8
BR122020006518B1 (pt) 2012-03-30 2022-02-22 Givaudan Sa Composição de sabor
SG11201405409PA (en) 2012-03-30 2014-11-27 Givaudan Sa N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds
US10913922B2 (en) 2012-03-30 2021-02-09 Givaudan S.A. N-acylated methionine derivatives as food flavoring compounds
EP2830441B1 (en) 2012-03-30 2019-11-13 Givaudan SA N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds
JP6209588B2 (ja) 2012-03-30 2017-10-04 ジボダン エス エー 食品フレーバー付与化合物としてのｎ−アシルプロリン誘導体
WO2013149025A1 (en) * 2012-03-30 2013-10-03 Givaudan, S., A. N-acyl serine derivatives as food flavouring compounds
CN104219963B (zh) 2012-03-30 2018-08-14 奇华顿股份有限公司 作为食品加香化合物的n-酰基-氨基酸衍生物、包含它们的粉末组合物
CN104302191A (zh) 2012-03-30 2015-01-21 奇华顿股份有限公司 用于改善可食用组合物香味特性的n-酰基-氨基酸衍生物
US10834943B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds having taste-modifying properties
EP3057448B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
WO2015048991A1 (en) 2013-10-02 2015-04-09 Givaudan Sa Organic compounds having taste-modifying properties
WO2015050536A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
CN105658089B (zh) 2013-10-02 2019-07-09 奇华顿股份有限公司 有机化合物
US10834950B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
CA3072735A1 (en) 2017-08-21 2019-02-28 Celgene Corporation Processes for the preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
CN109601739B (zh) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 一种复合氨基酸饲料添加剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4349466A (en) * 1978-11-14 1982-09-14 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
DE69228006T2 (de) * 1991-09-27 1999-08-12 Board of Regents, the University of Texas System, Austin, Tex. Parenteral anzuwendende Aminosäuren enthaltende Zubereitungen zur Bekämpfung von Hypotension und verwandten Pathologien

Also Published As

Publication number Publication date
US5312831A (en) 1994-05-17
HU9401444D0 (en) 1994-08-29
AU6304394A (en) 1994-11-17
KR100296543B1 (ko) 2001-11-22
US5658945A (en) 1997-08-19
NO941786D0 (no) 1994-05-11
US5602275A (en) 1997-02-11
ZA943266B (en) 1995-01-12
CZ98194A3 (en) 1994-12-15
CN1100413A (zh) 1995-03-22
HUT67038A (en) 1995-01-30
SK49194A3 (en) 1995-02-08
CN1094943C (zh) 2002-11-27
ES2094004T3 (es) 1997-01-01
SK281120B6 (sk) 2000-12-11
US5545662A (en) 1996-08-13
TW380129B (en) 2000-01-21
PH30182A (en) 1997-01-21
NO311223B1 (no) 2001-10-29
CZ290445B6 (cs) 2002-07-17
JP3583469B2 (ja) 2004-11-04
NO941786L (no) 1994-11-14
IL109602A (en) 2000-06-01
SG43071A1 (en) 1997-10-17
DE69400798T2 (de) 1997-03-13
AU669064B2 (en) 1996-05-23
FI942186A (fi) 1994-11-13
NZ260507A (en) 1996-02-27
EP0652228B1 (en) 1996-10-23
IL109602A0 (en) 1994-08-26
ATE144533T1 (de) 1996-11-15
RU2135515C1 (ru) 1999-08-27
EP0652228A1 (en) 1995-05-10
JPH07179414A (ja) 1995-07-18
US5616612A (en) 1997-04-01
DE69400798D1 (de) 1996-11-28
FI942186A0 (fi) 1994-05-11
SI0652228T1 (en) 1997-10-31
PL179984B1 (pl) 2000-11-30
GR3022253T3 (en) 1997-04-30
CA2123261A1 (en) 1994-11-13
US5633280A (en) 1997-05-27
HU219768B (hu) 2001-07-30

Similar Documents

Publication Publication Date Title
DK0652228T3 (da) Urethaner og urinstoffer, som fremkalder cytoproduktion
RU94016389A (ru) Карбаматы и карбамиды, индуцирующие производство цитокинов
IL150223A (en) Lipopeptides and pharmaceuticals containing them
DK0625989T3 (da) DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
DK0409472T3 (da) Knoglemorfogenetisk protein
DK0604418T3 (da) Isolerede viralproteincytokinantagonister
MY129376A (en) Novel pharmaceutical formulations of modafinil
SE0302139D0 (sv) Novel compounds
IL196900A (en) Autologous T cell vaccine compositions
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
YU174491A (sh) Vakcine
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
TW200500097A (en) Novel pharmaceutical formulations of modafinil
SE9902551D0 (sv) Novel compounds
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE295838T1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
DK1449535T3 (da) Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer
SE9902147L (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma